ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling
- PMID: 38008882
- PMCID: PMC10678915
- DOI: 10.1007/s12672-023-00832-x
ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling
Abstract
Small GTPases regulate multiple important cellular behaviors and their activities are strictly controlled by a mass of regulators. The dysfunction or abnormal expression of small GTPases or their regulators was frequently observed in various cancers. Here, we analyzed the expression and prognostic correlation of several GTPases and related regulators based on the TCGA database and found that Ankyrin Repeat and PH Domain 1 (ARAP1), a GTPase activating protein (GAP), is reduced in lung adenocarcinoma tissues compared to normal tissues and displays a positive correlation with overall survival (OS) and progression-free survival (PFS) of patients with lung adenocarcinoma. qPCR and western blot verified that ARAP1 is frequently downregulated in lung adenocarcinoma tumor tissues and cancer cells, and its downregulation might be mediated by epigenetic modification. Moreover, metastatic assays showed that overexpression of ARAP1 significantly inhibits metastasis of lung adenocarcinoma in vitro and in vivo. We further demonstrated that Rho signaling inhibition, mediated by RhoGAP activity of ARAP1, majorly contributes to suppressing migration and invasion of lung adenocarcinoma cancer cells via inhibiting stress fibers formation. In summary, this study indicates that ARAP1 may serve as a potential prognostic predictor and a metastatic suppressor in lung adenocarcinoma via its RhoGAP activity.
Keywords: ARAP1; GTPase; Lung adenocarcinoma; Metastasis; Rho; Stress fiber.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures






Similar articles
-
Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.Bioengineered. 2022 Mar;13(3):7868-7880. doi: 10.1080/21655979.2022.2050968. Bioengineered. 2022. PMID: 35291911 Free PMC article.
-
ARAP1: a point of convergence for Arf and Rho signaling.Mol Cell. 2002 Jan;9(1):109-19. doi: 10.1016/s1097-2765(02)00428-8. Mol Cell. 2002. PMID: 11804590
-
LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5.Cancer Biomark. 2023;38(2):177-189. doi: 10.3233/CBM-220223. Cancer Biomark. 2023. PMID: 37545214
-
Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.Cell Commun Signal. 2020 Sep 8;18(1):144. doi: 10.1186/s12964-020-00635-5. Cell Commun Signal. 2020. PMID: 32900380 Free PMC article.
-
Fixing the GAP: The role of RhoGAPs in cancer.Eur J Cell Biol. 2022 Apr;101(2):151209. doi: 10.1016/j.ejcb.2022.151209. Epub 2022 Feb 10. Eur J Cell Biol. 2022. PMID: 35180567 Free PMC article. Review.
Cited by
-
Biallelic variants identified in 36 Pakistani families and trios with autism spectrum disorder.Sci Rep. 2024 Apr 22;14(1):9230. doi: 10.1038/s41598-024-57942-x. Sci Rep. 2024. PMID: 38649688 Free PMC article.
-
Adaptation responses to salt stress in the gut of Poecilia reticulata.Anim Cells Syst (Seoul). 2025 Jan 18;29(1):84-99. doi: 10.1080/19768354.2025.2451413. eCollection 2025. Anim Cells Syst (Seoul). 2025. PMID: 39839657 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. - PubMed
Grants and funding
- LY21C070004/Zhejiang Provincial Natural Science Foundation of China
- LQ22H200003/Zhejiang Provincial Natural Science Foundation of China
- 2022E10022/Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
- 2022E10022/Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province
- KYYW2021026/the Fundamental Scientific Research Fees of Wenzhou Medical University
LinkOut - more resources
Full Text Sources
Miscellaneous